Dianthus Therapeutics Inc... (DNTH)
NASDAQ: DNTH
· Real-Time Price · USD
20.71
0.46 (2.27%)
At close: Aug 15, 2025, 3:59 PM
20.74
0.14%
After-hours: Aug 15, 2025, 04:10 PM EDT
Dianthus Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4.85M | 6.52M | 6.24M | 5.37M | 4.12M | 3.22M | 2.83M | 3.54M | 3.79M | 2.82M | 2.35M | 1.17M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 426K | 438K | 412K | 437K | 340K | 229K | 1.33M | 2.45M | 3.65M | 4.84M | 4.84M | 4.15M | 3.47M | 2.76M | 1.55M | 1.01M | 479K | n/a |
Gross Profit | 4.75M | 6.52M | 6.24M | 5.37M | 4.1M | 3.21M | 1.6M | 1.09M | 147K | -2.02M | -2.5M | -2.98M | -3.47M | -2.76M | -1.55M | -1.01M | -479K | n/a |
Operating Income | -129.92M | -117.2M | -101.86M | -82.9M | -68.76M | -52.02M | -48.3M | -46.04M | -38.53M | -51.16M | -60.86M | -70.31M | -80.3M | -79.83M | -74.69M | -73.62M | -73.75M | -76.16M |
Interest Income | 15.63M | 16.93M | 17.36M | 15.82M | 12.4M | 8.38M | 4.76M | 2.96M | 2.35M | 2.47M | 2.75M | 2.96M | 3.36M | 2.55M | 2.87M | 2.92M | 2.81M | 3.74M |
Pretax Income | -114.75M | -100.73M | -84.97M | -67.09M | -56.68M | -42.36M | -57.78M | -57.33M | -50.35M | -64.34M | -58.12M | -67.3M | -76.94M | -76.6M | -71.14M | -70.01M | -70.26M | -72.41M |
Net Income | -114.75M | -100.73M | -84.97M | -67.09M | -56.68M | -42.36M | -57.78M | -57.33M | -50.35M | -64.34M | -58.12M | -67.3M | -76.94M | -76.6M | -71.14M | -70.01M | -70.26M | -72.41M |
Selling & General & Admin | 29.56M | 26.69M | 24.99M | 22.8M | 24.99M | 21.49M | 21.98M | 19.38M | 12.87M | 16.86M | 18.01M | 23M | 28.24M | 28.24M | 27.93M | 27.71M | 26.85M | 27.77M |
Research & Development | 105.21M | 97.03M | 83.11M | 65.47M | 47.89M | 29.96M | 23.67M | 24.72M | 23.98M | 34.24M | 44M | 47.29M | 50.86M | 51.59M | 46.77M | 45.91M | 46.9M | 48.38M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -3K | -46K | -48K | -48K | -45K | -2K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 134.77M | 123.72M | 108.1M | 88.27M | 72.88M | 61.56M | 55.76M | 54.22M | 46.96M | 51.1M | 62.02M | 70.29M | 79.11M | 79.83M | 74.69M | 73.62M | 73.75M | 76.16M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.19M | 2M | 2.89M | 3.73M | 3.36M | 3.23M | 3.56M | 3.6M | 3.49M | 3.74M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 3.82M | 3.82M | 3.82M | 3.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 134.77M | 123.72M | 108.1M | 88.27M | 72.88M | 61.56M | 56.97M | 55.42M | 48.17M | 53.51M | 63.21M | 71.48M | 80.3M | 79.83M | 74.69M | 73.62M | 73.75M | 76.16M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 179K | 1.34M | 1.34M | 1.34M | 1.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 35.82M | 35.79M | 35.03M | 34.24M | 34.23M | 25.67M | 4.53M | 3.91M | 3.79M | 3.79M | 3.79M | 3.7M | 3.68M | 3.67M | 3.67M | 3.66M | 3.36M | 3.04M |
Shares Outstanding (Diluted) | 35.82M | 35.79M | 35.03M | 34.24M | 34.23M | 25.67M | 4.53M | 3.91M | 3.79M | 3.79M | 3.79M | 3.7M | 3.68M | 3.67M | 3.67M | 3.66M | 3.36M | 3.04M |
EPS (Basic) | -3.25 | -2.88 | -2.6 | -4.12 | -7.16 | -7.52 | -14.68 | -15.02 | -13.34 | -17.17 | -15.71 | -18.29 | -20.95 | -21.29 | -20.81 | -21.55 | -22.65 | -25.32 |
EPS (Diluted) | -3.25 | -2.88 | -2.6 | -4.12 | -7.16 | -7.52 | -14.68 | -15.02 | -13.34 | -17.17 | -15.71 | -18.29 | -20.95 | -21.29 | -20.81 | -21.55 | -22.65 | -25.32 |
EBITDA | -129.59M | -116.76M | -101.45M | -82.47M | -68.36M | -57.95M | -47.82M | -45.61M | -38.25M | -42.63M | -56.77M | -64.88M | -73.47M | -73.84M | -69.12M | -68.03M | -68.32M | -70.45M |
EBIT | -126.62M | -117.2M | -101.86M | -82.9M | -68.76M | -58.34M | -48.17M | -45.91M | -38.41M | -43.9M | -59.17M | -67.77M | -76.94M | -76.6M | -71.14M | -70.01M | -70.26M | -72.41M |
Depreciation & Amortization | 426K | 438K | 412K | 437K | 408K | 381K | 1.48M | 2.61M | 3.73M | 4.84M | 4.84M | 4.15M | 3.47M | 2.76M | 2.02M | 1.98M | 1.94M | 1.96M |